FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / ...

ABL Advisor Search Results

News Stories (12 Results) - Biotechnology

Radius Health announced that the Company has entered into amended and restated credit facilities in the aggregate principal amount of $175 million, consisting of a $150 million term loan, which includes a cashless conversion of $25 million in... Read Story

March 04, 2021, 08:05 AM

Harvard Bioscience, Inc. announced the refinancing of its debt with the closing of a new $65 million credit facility. Proceeds from the new facility will be used to retire existing debt and pay related fees and expenses. The Refinancing significantly... Read Story

December 23, 2020, 08:35 AM

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it has entered into a debt financing facility for up to $30 million (“debt facility”) with Silicon Valley Bank (SVB). The non-dilutive... Read Story

November 23, 2020, 08:15 AM

Fortress Biotech, an innovative revenue-generating company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and product candidates cost-effectively, announced that it has entered into a $60... Read Story

August 28, 2020, 08:05 AM

InformedDNA, the nation’s largest provider of genetics services, announced that it has entered into definitive agreements with TT Capital Partners (TTCP), NovaQuest Capital Management (NovaQuest) and Frist Cressey Ventures to make meaningful growth... Read Story

December 24, 2019, 08:50 AM

Capital One announced today that it acted as a joint lead arranger for a senior secured credit facility for STEMCELL Technologies, a Canada-based biotechnology and life science company. The financing consists of a revolving line of credit and a... Read Story

August 20, 2019, 08:50 AM

Meridian Bioscience has entered into a $125 million revolving credit facility credit agreement, it said in a regulatory filing.The credit agreement, which took effect on May 24, replaces the Cincinnati-based company's loan and security agreement... Read Story

June 03, 2019, 08:47 AM

Fueled by a desire for innovation and new medical breakthroughs, the biotech industry continues to enjoy substantial growth due to increased investment in research and development (R&D), according to the sixth annual study from BDO USA, LLP.The 2017... Read Story

July 17, 2017, 07:30 AM

Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, and Silicon Valley Bank announced the closing of a $20 million credit facility with Castle Biosciences, Inc., a privately held... Read Story

May 10, 2017, 07:18 AM

T2 Biosystems, Inc., a company developing innovative diagnostic products that improve patient health and deliver a strong economic return to healthcare institutions, today announced that it has entered into a $50 million debt facility agreement with... Read Story

January 06, 2017, 07:30 AM

Ocata Therapeutics, Inc. has entered into a secured term loan facility of up to $10 million with Silicon Valley Bank. Ocata received initial funding of $6 million and has a conditional option to receive an additional $4 million upon the successful... Read Story

August 20, 2015, 07:15 AM

Oxford Finance and Silicon Valley Bank announced the closing of a credit facility, including a $10 million senior secured term loan and a $7 million line of credit, with Labcyte Inc. Labcyte is a global biotechnology tools company that is... Read Story

May 06, 2015, 07:34 AM